JP2024523394A5 - - Google Patents
Info
- Publication number
- JP2024523394A5 JP2024523394A5 JP2023577861A JP2023577861A JP2024523394A5 JP 2024523394 A5 JP2024523394 A5 JP 2024523394A5 JP 2023577861 A JP2023577861 A JP 2023577861A JP 2023577861 A JP2023577861 A JP 2023577861A JP 2024523394 A5 JP2024523394 A5 JP 2024523394A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- target gene
- krab
- complex
- dnmt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163211791P | 2021-06-17 | 2021-06-17 | |
| US63/211,791 | 2021-06-17 | ||
| PCT/US2022/033797 WO2022266324A1 (en) | 2021-06-17 | 2022-06-16 | Systems and methods for regulating aberrant gene expressions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024523394A JP2024523394A (ja) | 2024-06-28 |
| JP2024523394A5 true JP2024523394A5 (enExample) | 2025-06-13 |
Family
ID=84525869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577861A Pending JP2024523394A (ja) | 2021-06-17 | 2022-06-16 | 異常な遺伝子発現を調節するためのシステムおよび方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240216482A1 (enExample) |
| EP (1) | EP4355357A4 (enExample) |
| JP (1) | JP2024523394A (enExample) |
| KR (1) | KR20240032038A (enExample) |
| CN (1) | CN117940150A (enExample) |
| AU (1) | AU2022293494A1 (enExample) |
| CA (1) | CA3221874A1 (enExample) |
| GB (1) | GB2624791A (enExample) |
| IL (1) | IL309174A (enExample) |
| MX (1) | MX2023014750A (enExample) |
| WO (1) | WO2022266324A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230076820A (ko) | 2020-09-01 | 2023-05-31 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 진핵생물 유전체 공학을 위한 합성 미니어처 crispr-cas(casmini) 시스템 |
| JP2025507822A (ja) | 2022-03-01 | 2025-03-21 | エピクリスパー バイオテクノロジーズ， インコーポレイテッド | 組換えヌクレアーゼならびにその組成物および使用方法 |
| CN121127598A (zh) * | 2023-03-16 | 2025-12-12 | 埃皮克里斯皮尔生物技术公司 | 用于调控异常基因表达的系统和方法 |
| CN119955797B (zh) * | 2025-01-13 | 2026-01-23 | 江南大学 | Kif5b基因在调控成肌细胞生理活性中的功能和应用 |
| CN119954926B (zh) * | 2025-03-11 | 2025-10-28 | 华南农业大学 | Klf5转录因子在调控猪骨骼肌发育中的应用及方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1107789B1 (en) | 1998-08-24 | 2008-06-25 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage |
| EP3443081A4 (en) * | 2016-04-13 | 2019-10-30 | Duke University | CRISPR / CAS9-BASED REPRESSORS FOR IN VIVO SHUT-OFF OF GEN-TARGETS AND METHOD OF USE |
| EP3515506B1 (en) * | 2016-09-23 | 2023-09-13 | University of Massachusetts | Silencing of dux4 by recombinant gene editing complexes |
| US11160823B2 (en) * | 2016-11-07 | 2021-11-02 | University Of Massachusetts | Therapeutic targets for facioscapulohumeral muscular dystrophy |
| US11807877B1 (en) * | 2018-03-22 | 2023-11-07 | National Technology & Engineering Solutions Of Sandia, Llc | CRISPR/Cas activity assays and compositions thereof |
| JP2022516515A (ja) * | 2018-12-31 | 2022-02-28 | リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル | Ｒｎａ標的化ｃｒｉｓｐｒ－ｃａｓ１３ｂを使用するｄｕｘ４ ｒｎａ発現停止 |
| WO2020142739A1 (en) * | 2019-01-04 | 2020-07-09 | Mammoth Biosciences, Inc. | COMPOSITIONS AND METHODS FOR DETECTING MODIFIED NUCLEIC ACIDS AND AMPLIFYING ssDNA |
| WO2022133062A1 (en) * | 2020-12-16 | 2022-06-23 | Epicrispr Biotechnologies, Inc. | Systems and methods for engineering characteristics of a cell |
-
2022
- 2022-06-16 JP JP2023577861A patent/JP2024523394A/ja active Pending
- 2022-06-16 IL IL309174A patent/IL309174A/en unknown
- 2022-06-16 GB GB2319324.6A patent/GB2624791A/en active Pending
- 2022-06-16 KR KR1020247001784A patent/KR20240032038A/ko active Pending
- 2022-06-16 MX MX2023014750A patent/MX2023014750A/es unknown
- 2022-06-16 CA CA3221874A patent/CA3221874A1/en active Pending
- 2022-06-16 CN CN202280056393.0A patent/CN117940150A/zh active Pending
- 2022-06-16 WO PCT/US2022/033797 patent/WO2022266324A1/en not_active Ceased
- 2022-06-16 AU AU2022293494A patent/AU2022293494A1/en active Pending
- 2022-06-16 EP EP22825819.0A patent/EP4355357A4/en active Pending
-
2023
- 2023-12-15 US US18/542,396 patent/US20240216482A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3042358C (en) | Zinc fingers and related adenovirus-associated virus vectors for the treatment of polyglutamine diseases, such as Huntington's disease | |
| JP7069426B2 (ja) | ユートロフィン遺伝子を標的とした筋ジストロフィーの治療方法 | |
| KR20240011120A (ko) | 후성유전학적 편집을 위한 조성물 및 방법 | |
| US20220127621A1 (en) | Fusion proteins and fusion ribonucleic acids for tracking and manipulating cellular rna | |
| JP2023552374A5 (enExample) | ||
| JP2024520528A5 (enExample) | ||
| JP2023544683A5 (enExample) | ||
| JP2021520203A5 (enExample) | ||
| JP2023518541A5 (enExample) | ||
| WO2021178717A2 (en) | Improved methods and compositions for modulating a genome | |
| JP2021526858A5 (enExample) | ||
| RU2019103691A (ru) | Искусственно сконструированная система регуляции ангиогенеза | |
| JP2020508685A5 (enExample) | ||
| RU2018101710A (ru) | Мутации фермента crispr, уменьшающие нецелевые эффекты | |
| GB2624791A (en) | Systems and methods for regulating aberrant gene expressions | |
| CN119013310A (zh) | 具有改善的编辑精确度的突变的胞嘧啶脱氨酶 | |
| WO2020069339A8 (en) | Mutant reverse tetracycline transactivators for expression of genes | |
| JP2013509168A5 (enExample) | ||
| JP2020533411A5 (enExample) | ||
| RU2022105597A (ru) | Искусственно созданная система управления функцией шк | |
| JP2023543154A5 (enExample) | ||
| JP2024515827A5 (enExample) | ||
| JP2025521581A (ja) | エピジェネティック編集用の組成物および方法 | |
| JP2024503091A5 (enExample) | ||
| JP2024522764A5 (enExample) |